Family Gatherings: A Great Time to Ask About Health History Read Our Tips Join us in a career at CSL Behring! We offer Promising FUTURES. How to Be an Ally for Someone With a Rare Disease CSL’s Response to COVID-19 Despite the constantly challenging environment the COVID-19 pandemic has presented to the world, CSL has remained steadfast in our promise to safeguarding our patients, our plasma donors and our employees. As the pandemic continues to evolve, so have we. CSL has redirected resources and taken on extra commitments to protect public health where we could offer the most value, including our expertise, technologies, equipment and materials. And through it all, we continue to deliver on our promise for those who need us most, our patients. Read More About CSL Behring's Efforts with COVID-19 Community Group Honors CSL Behring in Australia Banksia Gardens Community Services says thank you for a grant program and pro bono legal assistance. 23 Nov 2021 Do You Know Your Family's Health History? Fall and winter gatherings remind us of the ties that bind – and present an opportunity to learn about health problems that r… 22 Nov 2021 CEO Paul Perreault at the 2021 STAT Summit Leaders in science convened to discuss the most pressing topics in biotech, medicine and policy at the 2021 STAT Summit. 19 Nov 2021 Explainer: What Is Seasonal Flu? Health officials recommend getting vaccinated against seasonal influenza, but do you know why? For one thing, the flu is alwa… 18 Nov 2021 Facebook Connects the Rare Disease Community While the platform faces scrutiny, many say it’s a lifeline for patients desperate to find one another. 17 Nov 2021 A Big Push for Decentralized Trials More remote monitoring, fewer visits to a research center would make it easier for participants to take part in clinical tria… 16 Nov 2021 Hands-Free Thanks to Augmented Reality To make manufacturing smarter, a pilot plant in Australia is exploring how to replace paper with next-generation technology. 15 Nov 2021 Humanitarian Aid for Patients The World Federation of Hemophilia (WFH) celebrates a milestone: one billion donated units of clotting factor distributed to … 12 Nov 2021 Researching Future Pandemics and Cancer Mysteries Two Australian scientists win fellowships each worth AUD $1.25 million to transform our response to pandemics and explore pot… 11 Nov 2021 Read More Vita Stories Browse All Topics Short, sweet and once a week Subscribe to get three stories each week about rare disease patients and biotech innovations. Subscribe Our Focus on Serious & Rare Diseases Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency. Read More Become a Part of Our Future Join a global biotechnology leader. We’re ready for you! Learn More About Careers at CSL Behring Our Products Discover CSL Behring's life-saving therapies. See Our Global Products List Clinical Trials Find out how to participate. Learn More About Our Studies Latest News Find out what's happening now at CSL Behring. Read Our News Releases Get our latest Vita stories in your inbox Email Contact CSL, All Rights Reserved © 2021 Terms of Use Cookie Policy Privacy Policy Accessibility Statement Patents Sitemap By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies